Phase I/IB trial of eribulin and everolimus in patients with triple-negative metastatic breast cancer.

被引：1
|
作者：
Luu, Thehang H. [1 ]
Blanchard, Suzette [1 ]
Yim, John Hosei [1 ]
机构：
[1] City Hope Canc Ctr, Beckman Res Inst, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.tps2637
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2637
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer
    Liu, Jieqiong
    Wang, Ying
    Tian, Zhenluan
    Lin, Ying
    Li, Hengyu
    Zhu, Zhaowen
    Liu, Qiang
    Su, Shicheng
    Zeng, Yinduo
    Jia, Weijuan
    Yang, Yaping
    Xu, Shengqiang
    Yao, Herui
    Jiang, Wen
    Song, Erwei
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [42] Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer
    Jieqiong Liu
    Ying Wang
    Zhenluan Tian
    Ying Lin
    Hengyu Li
    Zhaowen Zhu
    Qiang Liu
    Shicheng Su
    Yinduo Zeng
    Weijuan Jia
    Yaping Yang
    Shengqiang Xu
    Herui Yao
    Wen Jiang
    Erwei Song
    Nature Communications, 13
  • [43] A phase II study of tivantinib (ARQ-197) for metastatic triple-negative breast cancer.
    Tolaney, Sara M.
    Guo, Hao
    Barry, William Thomas
    Larrabee, Katherine
    Brock, Jane E.
    Wagle, Nikhil
    Van Allen, Eliezer Mendel
    Paweletz, Cloud
    Ivanova, Elena
    Janne, Pasi A.
    Overmoyer, Beth
    Wright, John Joseph
    Shapiro, Geoffrey
    Winer, Eric P.
    Krop, Ian E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial
    Loap, Pierre
    Loirat, Delphine
    Berger, Frederique
    Rodrigues, Manuel
    Bazire, Louis
    Pierga, Jean-Yves
    Vincent-Salomon, Anne
    Laki, Fatima
    Boudali, Latifa
    Raizonville, Laurence
    Mosseri, Veronique
    Jochem, Anne
    Eeckhoutte, Alexandre
    Diallo, Mamadou
    Stern, Marc-Henri
    Fourquet, Alain
    Kirova, Youlia
    JAMA ONCOLOGY, 2022, 8 (12) : 1802 - 1808
  • [45] Results of a phase Ib study investigating durvalumab in combination with eribulin in patients with metastatic HER2-negative breast cancer and recurrent ovarian cancer.
    Landry, Chrystal Ann
    Ru, Meng
    Hickson, Christopher
    Klein, Paula
    Fasano, Julie
    Bhardwaj, Aarti
    Shapiro, Charles L.
    Irie, Hanna
    Shao, Theresa
    Selkridge, Isaiah
    Tiersten, Amy
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] Phase 2 study of eribulin mesylate in combination with carboplatin in patients with advanced triple negative breast cancer.
    Michalaki, Vasiliki
    Karvouni, Eleni
    Dafnios, Nikolaos
    Psychogios, Christos
    Vasiliou, John
    Papadimitriou, Christos A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer
    Tolaney, S.
    Savulsky, C.
    Aktan, G.
    Xing, D.
    Almonte, A.
    Karantza, V.
    Diab, S.
    CANCER RESEARCH, 2017, 77
  • [48] Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer
    Tolaney, Sara M.
    Kalinsky, Kevin
    Kaklamani, Virginia
    Savulsky, Claudio
    Olivo, Martin
    Aktan, Gursel
    Kaufman, Peter A.
    Xing, Dongyuan
    Almonte, Ana
    Misir, Soamnauth
    Karantza, Vassiliki
    Diab, Sami
    CANCER RESEARCH, 2018, 78 (04)
  • [49] Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer
    Tolaney, Sara M.
    Kalinsky, Kevin
    Kaklamani, Virginia
    Savulsky, Claudio
    Olivo, Martin
    Aktan, Gursel
    Kaufman, Peter A.
    Xing, Dongyuan
    Almonte, Ana
    Misir, Soamnauth
    Karantza, Vassiliki
    Young, Louise
    Diab, Sami
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 176 - 176
  • [50] Phase Ib trial of atezolizumab in combination with nab-paclitaxel in patients with metastatic triple negative breast cancer (mTNBC).
    Adams, Sylvia
    Diamond, Jennifer Robinson
    Hamilton, Erika Paige
    Pohlmann, Paula Raffin
    Tolaney, Sara M.
    Molinero, Luciana
    He, Xian
    Waterkamp, Daniel
    Funke, Roel Peter
    Powderly, John D.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345